Coronary artery disease (CAD) is a risk for HIV patients due to interactions between the virus and traditional risk factors like smoking, diabetes, and hypertension. Studies have shown HIV patients can develop plaques and experience atherosclerosis even without metabolic abnormalities, leading to a higher risk of CAD. It is important to prevent CAD in HIV patients through health monitoring and risk factor reduction, as identifying and treating at-risk patients with both HIV and cardiovascular complications can be challenging.
Coronary artery disease (CAD) is a risk for HIV patients due to interactions between the virus and traditional risk factors like smoking, diabetes, and hypertension. Studies have shown HIV patients can develop plaques and experience atherosclerosis even without metabolic abnormalities, leading to a higher risk of CAD. It is important to prevent CAD in HIV patients through health monitoring and risk factor reduction, as identifying and treating at-risk patients with both HIV and cardiovascular complications can be challenging.
Coronary artery disease (CAD) is a risk for HIV patients due to interactions between the virus and traditional risk factors like smoking, diabetes, and hypertension. Studies have shown HIV patients can develop plaques and experience atherosclerosis even without metabolic abnormalities, leading to a higher risk of CAD. It is important to prevent CAD in HIV patients through health monitoring and risk factor reduction, as identifying and treating at-risk patients with both HIV and cardiovascular complications can be challenging.
of patients suffering from this infection continues to increase. According to the 2013 World Health Organization report, the number of patients worldwide is 35 million with more than 1 million patients dying of HIV-related diseases every year. Apart from the obvious implications of HIV such as the development of AIDS, other potentially deadly complications may arise, one of which is the effect of suffering from HIV on the coronary system. HIV patients can develop coronary artery disease at a very young age.
The relationship of coronary heart disease (CHD)
and human immune virus infection has been known for years. The etiology of increasing prevalence of CHD in HIV-infected populations is the result of complex interactions between viral infections. Many studies show that smokers, dyslipidemia, diabetes, hypertension which are traditional risk factors for CAD can increase the risk of CAD in HIV-infected patients.
Several studies have discussed the nature of
atherosclerotic lesions in HIV-infected populations. They concluded that HIV patients without significant metabolic abnormalities could still develop uncalcified plaques and therefore a higher risk for coronary artery disease (CAD).
Other studies assessed the increased risk of
atherosclerosis in HIV-infected patients by measuring intima- carotid media thickness (BMI) in 145 HIV patients who were taking antiretroviral therapy for at least 6 months. They revealed that 34 (23.4%) of these patients had carotid plaques associated with three independent risk factors.
In conclusion, "it is better to prevent than cure" we
often hear these words. This means that it is better for us to care for and care for our bodies before things that are not cold occur so care must be taken. In this case, prevention of coronary artery disease (CAD) in HIV-infected patients should be a major concern. Because there are many things that make it difficult to identify and treat these at-risk patients.